EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Overexpression of Both Human Sodium Iodide Symporter (NIS) and BRG1-Bromodomain Synergistically Enhances Radioiodine Sensitivity by Stabilizing p53 through NPM1 Expression

Juri Na iD, Chul-Hee Lee iD, June-Key Chung, Hyewon Youn

International Journal of Molecular Sciences · 2023

DOI: 10.3390/ijms24032761 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Juri Na und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nuclear Medicine, Seoul National University College of Medicine, Seoul 03080, Republic of Korea. Hauptthemen laut MEDLINE: Iodine Radioisotopes, Symporters. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 77 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Research Foundation of Korea.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Improved therapeutic strategies are required to minimize side effects associated with radioiodine gene therapy to avoid unnecessary damage to normal cells and radiation-induced secondary malignancies. We previously reported that codon-optimized sodium iodide symporter (oNIS) enhances absorption of I-131 and that the brahma-associated gene 1 bromodomain (BRG1-BRD) causes inefficient DNA damage repair after high-energy X-ray therapy. To increase the therapeutic effect without applying excessive radiation, we considered the combination of oNIS and BRG1-BRD as gene therapy for the most effective radioiodine treatment. The antitumor effect of I-131 with oNIS or oNIS+BRD expression was examined by tumor xenograft models along with functional assays at the cellular level. The synergistic effect of both BRG1-BRD and oNIS gene overexpression resulted in more DNA double-strand breaks and led to reduced cell proliferation/survival rates after I-131 treatment, which was mediated by the p53/p21 pathway. We found increased p53, p21, and nucleophosmin 1 (NPM1) in oNIS- and BRD-expressing cells following I-131 treatment, even though the remaining levels of citrulline and protein arginine deiminase 4 (PAD4) were unchanged at the protein level.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Iodine RadioisotopesSymportersHumansCell Line, TumorTumor Suppressor Protein p53Sodium-Iodide SymportersDNA HelicasesNuclear ProteinsTranscription FactorsNucleophosmin

Stichwörter der Autor:innen

brahma-related gene 1 bromodomainiodine-131radioiodine therapyradiosensitizationsodium iodide symporterthyroid cancer

Substanzen

Iodine RadioisotopesSymportersTumor Suppressor Protein p53Sodium-Iodide SymportersIodine-131SMARCA4 protein, humanDNA HelicasesNuclear ProteinsTranscription FactorsNPM1 protein, human

Autor:innen und Institutionen

  • Department of Nuclear Medicine, Seoul National University College of Medicine, Seoul 03080, Republic of Korea.
  • Cancer Research Institute, Seoul National University College of Medicine, Seoul 03080, Republic of Korea.
  • Cancer Imaging Centre, Seoul National University Hospital, Seoul 03080, Republic of Korea.

ORCID-Profile: Juri Na, Chul-Hee Lee

Förderung

  • National Research Foundation of Korea

Zitieren

APA

Na, J., Lee, C. H., Chung, J. K., & Youn, H. (2023). Overexpression of Both Human Sodium Iodide Symporter (NIS) and BRG1-Bromodomain Synergistically Enhances Radioiodine Sensitivity by Stabilizing p53 through NPM1 Expression. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms24032761

Vancouver

Na J, Lee CH, Chung JK, Youn H. Overexpression of Both Human Sodium Iodide Symporter (NIS) and BRG1-Bromodomain Synergistically Enhances Radioiodine Sensitivity by Stabilizing p53 through NPM1 Expression. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms24032761

BibTeX
@article{Na2023,
  author = {Na, Juri and Lee, Chul-Hee and Chung, June-Key and Youn, Hyewon},
  title = {Overexpression of Both Human Sodium Iodide Symporter (NIS) and BRG1-Bromodomain Synergistically Enhances Radioiodine Sensitivity by Stabilizing p53 through NPM1 Expression},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  doi = {10.3390/ijms24032761}
}
Kostenlos starten →